Asia « Science and Enterprise

$15M Alternative Chicken, Fish Challenge Finalists Named

By Alan, on May 10th, 2023%

An international challenge competition seeking sustainable but realistic alternatives to natural chicken and fish protein named its six finalist teams. . . . → Read More: $15M Alternative Chicken, Fish Challenge Finalists Named

Chewable Covid-19 Drug Reduces Viral Load, Symptoms

By Alan, on March 29th, 2023%

Clinical trial results show an experimental drug given as a chewable tablet reduces viral load and symptoms in people with mild to moderate Covid-19 disease. . . . → Read More: Chewable Covid-19 Drug Reduces Viral Load, Symptoms

New Venture Funds to Back Life Science, Tech Start-Ups

By Alan, on January 26th, 2023%

Three new venture funds are seeking to invest up to $6.3 billion in start-up companies with advances in life sciences, health care, energy, and information technologies. . . . → Read More: New Venture Funds to Back Life Science, Tech Start-Ups

Peptide Discovery Company to Gain $3.3B in Licensing Deals

By Alan, on December 27th, 2022%

A discoverer of therapeutic peptides signed licensing deals in the past few days with two drug makers that could bring the company as much as $3.3 billion. . . . → Read More: Peptide Discovery Company to Gain $3.3B in Licensing Deals

AI Analytics Find New ALS Genetic Drug Targets

By Alan, on July 8th, 2022%

Researchers analyzed medical and scientific databases with algorithms to identify eight previously unreported biomarkers contributing to neurodegeneration similar to ALS. . . . → Read More: AI Analytics Find New ALS Genetic Drug Targets

AI Image Analysis Shown to Predict Embryo Health

By Alan, on June 28th, 2022%

An algorithm designed to analyze microscopic images is shown to largely predict the genetic integrity of embryos from in-vitro fertilization. . . . → Read More: AI Image Analysis Shown to Predict Embryo Health

Roche, Global Fund to Build Local Diagnostic Processes

By Alan, on May 12th, 2022%

The medical products company Roche is partnering with the Global Fund to develop systems and processes for disease diagnostics in low-resource regions. . . . → Read More: Roche, Global Fund to Build Local Diagnostic Processes

Biotech, Synthetic Bio Companies Partner on T-Cell Therapies

By Alan, on April 7th, 2022%

A company creating antibodies from synthetic DNA and a developer of engineered T-cells are collaborating on new antibodies to produce T-cell therapeutics. . . . → Read More: Biotech, Synthetic Bio Companies Partner on T-Cell Therapies

Clinical Trial Set for AI-Driven Lung Fibrosis Drug

By Alan, on February 25th, 2022%

A clinical trial is set to begin testing the safety and chemical activity of a drug candidate for lung fibrosis, discovered and refined with artificial intelligence. . . . → Read More: Clinical Trial Set for AI-Driven Lung Fibrosis Drug

Pharma Company Licenses Protein Delivery Hydrogel

By Alan, on February 11th, 2022%

A drug maker acquired commercialization rights to an injectable hydrogel developed at a university lab that delivers proteins to repair diseased tissue. . . . → Read More: Pharma Company Licenses Protein Delivery Hydrogel

Subscribe for email alerts

Donate to Science & Enterprise

Like us on Facebook

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Specials

Guest Posts

Please share Science & Enterprise